MetLife, Inc.
METLast close · Oct 16, 2026100.76+0.49 (+0.49%)
Market cap$64.0B
6 firms' latest targets, last 90 days: median $110.00 ($109.00–$111.00), 9% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-07 | Mizuho Securities | $109.00 | ▲ 15% | +8% |
| 2026-10-07 | Barclays | $111.00 | ▲ 14% | +10% |
| 2026-10-06 | UBS | $110.00 | ▲ 5% | +9% |
| 2026-09-22 | Piper Sandler | $110.00 | ▲ 22% | +9% |
| 2026-08-24 | Morgan Stanley | $111.00 | ▲ 8% | +10% |
| 2026-08-19 | Wells Fargo | $109.00 | ▲ 15% | +8% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2022reported | $2.1B | +2% | $2.91 | -60% | est. $77.3B-97% | est. $6.95 | 2 |
| 2023reported | $2.2B | +6% | $1.81 | -38% | est. $71.4B-97% | est. $7.31 | 6 |
| 2024reported | $2.2B | +1% | $5.94 | +228% | est. $72.8B-97% | est. $8.20 | 7 |
| 2025reported | $2.4B | +9% | $4.71 | -21% | est. $83.1B-97% | est. $8.69 | 4 |
| 2026 | $79.3B | +3156% | $10.23 | +18% | $78.9B–$79.9B | $7.43–$10.80 | 8 |
| 2027 | $83.3B | +5% | $11.15 | +9% | $80.8B–$84.9B | $7.58–$12.08 | 8 |
| 2028 | $86.7B | +4% | $12.46 | +12% | $84.1B–$89.1B | $10.90–$13.71 | 8 |
| 2029 | $92.9B | +7% | $13.60 | +9% | $90.5B–$95.2B | $13.14–$14.03 | 6 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.